The synergistic effect between dP@mVLP/RNAic-MET and TMZ was identified at multiple doses with complete cancer eradication with 5 mg/kg of dP@mVLP/RNAic-MET at a normal TMZ patient dose. The gene discussed is MET; the disease is cancer.